POM POMDOCTOR LIMITED
$0.73▼ -1.60%
Healthcare
Other
After hours
$0.71▼ -2.67%
Sep 11, 7:30 PM ET
Volume 2.9K
Avg Volume (10D) 19.7K
Key Metrics & Fundamentals
Market Cap
$6.77M
P/E Ratio
–
Div Yield
–%
52W Range
0.50 - 115.74
% vs 50 MA
-25.75%
% vs 200 MA
-91.08%
RSI-14
37.0
MACD Histogram
-0.0200
Beta (1Y vs SPY)
0.99
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News

POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
PR Newswire · Sep 10, 2026 12:00 PM

POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy
PR Newswire · Aug 27, 2026 12:00 PM
POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine
PR Newswire · Aug 10, 2026 12:00 PM
POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure
PR Newswire · Aug 3, 2026 12:00 PM
POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities
PR Newswire · Jul 15, 2026 12:00 PM
Pomdoctor Says It Has Regained Compliance with Nasdaq Minimum Bid Price Rule
MT Newswires · Jul 13, 2026 1:40 PM
POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
PR Newswire · Jul 13, 2026 12:00 PM
POMDOCTOR LIMITED Continues to Advance AI-Enabled Chronic Disease Management Strategy Amid Growing Demand for Predictive Healthcare
PR Newswire · Jul 9, 2026 12:00 PM
POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services
PR Newswire · Jul 2, 2026 12:00 PM
POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026
PR Newswire · Jun 17, 2026 10:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for POM.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.